Mon, October 31, 2016
Fri, October 28, 2016

Vamil Divan Upgraded (TEVA) to Buy on, Oct 31st, 2016

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. divan-upgraded-teva-to-buy-on-oct-31st-2016.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Vamil Divan of Credit Suisse, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Buy on, Oct 31st, 2016.

Vamil has made no other calls on TEVA in the last 4 months.



There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 1 agrees with Vamil's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Irina Rivkind Koffler of "Mizuho" Downgraded from Strong Buy to Hold on, Monday, October 24th, 2016


These are the ratings of the 3 analyists that currently disagree with Vamil


  • Derek Archila of "Oppenheimer" Upgraded from Hold to Buy on, Friday, September 2nd, 2016
  • Ami Fadia of "Leerink Swann" Maintained at Buy with Decreased Target to $61 on, Wednesday, August 31st, 2016
  • Tim Chiang of "BTIG" Maintained at Strong Buy and Held Target at $75 on, Wednesday, August 24th, 2016